Diabetic Dyslipidemia and Cardiovascular Risk

被引：6

作者：

Eckel, Robert H. ^{[1
]}

机构：

[1] Univ Colorado Denver, Div Endocrinol Diabet & Metab, Aurora, CO 80045 USA

来源：

CURRENT DIABETES REPORTS | 2008年 / 8卷 / 06期

关键词：

D O I：

10.1007/s11892-008-0072-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：421 / 423

页数：3

共 21 条

[1]

Anderson R N, 2001, Natl Vital Stat Rep, V49, P1

[2] Action to control cardiovascular risk in diabetes (ACCORD) trial: Design and methods [J].

Buse, John B. .

AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (12A) :21I-33I

[3] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[4] Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials [J].

Costa, Joao ;

Borges, Margarida ;

David, Claudio ;

Carneiro, Antnio Vaz .

BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7550) :1115-1118C

[5] Effect of type 1 diabetes on the gender difference in coronary artery calcification: A role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) study [J].

Dabelea, D ;

Kinney, G ;

Snell-Bergeon, JK ;

Hokanson, JE ;

Eckel, RH ;

Ehrlich, J ;

Garg, S ;

Hamman, RF ;

Rewers, M .

DIABETES, 2003, 52 (11) :2833-2839

[6] Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].

Dormandy, JA ;

Charbonnel, B ;

Eckland, DJA ;

Erdmann, E ;

Massi-Benedetti, M ;

Kmoules, IK ;

Skene, AM ;

Tan, MH ;

Lefébvre, PJ ;

Murray, GD ;

Standl, E ;

Wilcox, RG ;

Wlhelmsen, L ;

Betteridge, J ;

Birkeland, K ;

Golay, A ;

Heine, RJ ;

Korányi, L ;

Laakso, M ;

Mokán, M ;

Norkus, A ;

Pirags, V ;

Podar, T ;

Scheen, A ;

Scherbaum, W ;

Schernthaner, G ;

Schmitz, O ;

Skrha, J ;

Smith, U ;

Taton, J .

LANCET, 2005, 366 (9493) :1279-1289

[7] The metabolic syndrome [J].

Eckel, RH ;

Grundy, SM ;

Zimmet, PZ .

LANCET, 2005, 365 (9468) :1415-1428

[8] APOLIPOPROTEIN-E2 AND HYPERLIPOPROTEINEMIA IN NONINSULIN-DEPENDENT DIABETES-MELLITUS [J].

ETO, M ;

WATANABE, K ;

SATO, T ;

MAKINO, I .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (06) :1207-1212

[9] Are predictors of coronary heart disease and lower-extremity arterial disease in type I diabetes the same? A prospective study [J].

Forrest, KYZ ;

Becker, DJ ;

Kuller, LH ;

Wolfson, SK ;

Orchard, TJ .

ATHEROSCLEROSIS, 2000, 148 (01) :159-169

[10] Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [J].

Grundy, SM ;

Cleeman, JI ;

Daniels, SR ;

Donato, KA ;

Eckel, RH ;

Franklin, BA ;

Gordon, DJ ;

Krauss, RM ;

Savage, PJ ;

Smith, SC ;

Spertus, JA ;

Costa, F .

CIRCULATION, 2005, 112 (17) :2735-2752

← 1 2 3 →